Ipca Lab share price jumps over 7% to touch 52-week high on positive USFDA inspection report
Ipca Labs shares surge 7% as USFDA gives voluntary action indicated (VAI )classification to its manufacturing plant.23-10-2023
23-10-2023
IPCA LABORATORIES LTD. - 524494 - Classification Of USFDA Inspection For Our Manufacturing Facility At Ratlam, Madhya Pradesh
Classification of USFDA Inspection for our manufacturing facility at Ratlam, Madhya Pradesh21-10-2023
IPCA LABORATORIES LTD. - 524494 - Appointment Of Mr. Hitesh Kumar Maheshwari As President - R&D (Formulations)
Appointment of Mr. Hitesh Kumar Maheshwari as President - R&D (Formulations)16-10-2023
IPCA LABORATORIES LTD. - 524494 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2023.10-10-2023
IPCA LABORATORIES LTD. - 524494 - Closure of Trading Window
Closure of Trading Window with effect from closure of business hours on 30th September, 2023 and untill 48 hours after declaration of unaudited financial results.28-09-2023
IPCA LABORATORIES LTD. - 524494 - Announcement under Regulation 30 (LODR)-Open Offer - Updates
Further acquisition of 1,35,79,571 equity shares of Rs. 2/- each representing 19.29% of the paid-up share capital of Unichem Laboratories Ltd. under open offer.21-09-2023
IPCA LABORATORIES LTD. - 524494 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Compliance under Regulation 39(3) of the Securities and Exchange Board of India (LODR) Regulations, 201518-09-2023
Ipca Laboratories gains 3% on USFDA classification
The classification, considered the second best, comes after the pharma company's Piparia facility in Silvassa had undergone US FDA inspection in April.24-08-2023
IPCA LABORATORIES LTD. - 524494 - USFDA Inspection Update Of Piparia Formulations Manufacturing Facility
USFDA Inspection Update of Piparia formulations manufacturing facility24-08-2023
Hold Ipca Laboratories; target of Rs 880: Prabhudas Lilladher
Prabhudas Lilladher recommended hold rating on Ipca Laboratories with a target price of Rs 880 in its research report dated August 13, 2023.17-08-2023